BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7515683)

  • 1. Folding of insulin-like growth factor I is thermodynamically controlled by insulin-like growth factor binding protein.
    Hober S; Hansson A; Uhlén M; Nilsson B
    Biochemistry; 1994 Jun; 33(22):6758-61. PubMed ID: 7515683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disulfide exchange folding of disulfide mutants of insulin-like growth factor I in vitro.
    Hober S; Uhlén M; Nilsson B
    Biochemistry; 1997 Apr; 36(15):4616-22. PubMed ID: 9109671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factors I and II are unable to form and maintain their native disulfides under in vivo redox conditions.
    Hober S; Lundström Ljung J; Uhlén M; Nilsson B
    FEBS Lett; 1999 Jan; 443(3):271-6. PubMed ID: 10025946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The different folding behavior of insulin and insulin-like growth factor 1 is mainly controlled by their B-chain/domain.
    Guo ZY; Shen L; Feng YM
    Biochemistry; 2002 Feb; 41(5):1556-67. PubMed ID: 11814349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The different energetic state of the intra A-chain/domain disulfide of insulin and insulin-like growth factor 1 is mainly controlled by their B-chain/domain.
    Guo ZY; Shen L; Feng YM
    Biochemistry; 2002 Aug; 41(34):10585-92. PubMed ID: 12186542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative refolding of insulin-like growth factor 1 yields two products of similar thermodynamic stability: a bifurcating protein-folding pathway.
    Miller JA; Narhi LO; Hua QX; Rosenfeld R; Arakawa T; Rohde M; Prestrelski S; Lauren S; Stoney KS; Tsai L
    Biochemistry; 1993 May; 32(19):5203-13. PubMed ID: 8494897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Refolding of amphioxus insulin-like peptide: implications of a bifurcating evolution of the different folding behavior of insulin and insulin-like growth factor 1.
    Wang S; Guo ZY; Shen L; Zhang YJ; Feng YM
    Biochemistry; 2003 Aug; 42(32):9687-93. PubMed ID: 12911310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequences of B-chain/domain 1-10/1-9 of insulin and insulin-like growth factor 1 determine their different folding behavior.
    Chen Y; You Y; Jin R; Guo ZY; Feng YM
    Biochemistry; 2004 Jul; 43(28):9225-33. PubMed ID: 15248780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The sequence determinant causing different folding behaviors of insulin and insulin-like growth factor-1.
    Huang QL; Zhao J; Tang YH; Shao SQ; Xu GJ; Feng YM
    Biochemistry; 2007 Jan; 46(1):218-24. PubMed ID: 17198392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of native disulfide bonds in the structure and activity of insulin-like growth factor 1: genetic models of protein-folding intermediates.
    Narhi LO; Hua QX; Arakawa T; Fox GM; Tsai L; Rosenfeld R; Holst P; Miller JA; Weiss MA
    Biochemistry; 1993 May; 32(19):5214-21. PubMed ID: 8494898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation of Arg55/56 to Leu55/Ala56 in insulin-like growth factor-I results in two forms different in disulfide structure and native conformation but similar under reverse-phase conditions.
    Rosenfeld RD; Noone NM; Lauren SL; Rohde MF; Narhi LO; Arakawa T
    J Protein Chem; 1993 Jun; 12(3):247-54. PubMed ID: 8397784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disulfide exchange folding of insulin-like growth factor I.
    Hober S; Forsberg G; Palm G; Hartmanis M; Nilsson B
    Biochemistry; 1992 Feb; 31(6):1749-56. PubMed ID: 1737028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probing the disulfide folding pathway of insulin-like growth factor-I.
    Milner SJ; Carver JA; Ballard FJ; Francis GL
    Biotechnol Bioeng; 1999 Mar; 62(6):693-703. PubMed ID: 9951525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the B-domain of insulin-like growth factor-I influence the oxidative folding to yield products with modified biological properties.
    Milner SJ; Francis GL; Wallace JC; Magee BA; Ballard FJ
    Biochem J; 1995 Jun; 308 ( Pt 3)(Pt 3):865-71. PubMed ID: 8948444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intra-A chain disulphide bond forms first during insulin precursor folding.
    Yuan Y; Wang ZH; Tang JG
    Biochem J; 1999 Oct; 343 Pt 1(Pt 1):139-44. PubMed ID: 10493922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Putative folding pathway of insulin-like growth factor-I.
    Rosenfeld RD; Miller JA; Narhi LO; Hawkins N; Katta V; Lauren S; Weiss MA; Arakawa T
    Arch Biochem Biophys; 1997 Jun; 342(2):298-305. PubMed ID: 9186491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The folding nucleus of the insulin superfamily: a flexible peptide model foreshadows the native state.
    Hua QX; Mayer JP; Jia W; Zhang J; Weiss MA
    J Biol Chem; 2006 Sep; 281(38):28131-42. PubMed ID: 16864583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IGF binding proteins and their functions.
    Clemmons DR
    Mol Reprod Dev; 1993 Aug; 35(4):368-74; discussion 374-5. PubMed ID: 7691098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The thermodynamic stability of insulin disulfides is not affected by the C-domain of insulin-like growth factor 1.
    Guo Z; Feng Y
    Sci China C Life Sci; 2002 Jun; 45(3):245-50. PubMed ID: 18759047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probing the folding pathways of long R(3) insulin-like growth factor-I (LR(3)IGF-I) and IGF-I via capture and identification of disulfide intermediates by cyanylation methodology and mass spectrometry.
    Yang Y; Wu J; Watson JT
    J Biol Chem; 1999 Dec; 274(53):37598-604. PubMed ID: 10608814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.